CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 122 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,949,573 | -37.1% | 1,188,764 | +97.2% | 0.00% | -100.0% |
| Q1 2024 | $3,098,917 | -18.1% | 602,902 | -8.7% | 0.00% | 0.0% |
| Q4 2023 | $3,782,029 | +100.0% | 660,040 | +66.8% | 0.00% | – |
| Q3 2023 | $1,891,011 | +64.4% | 395,609 | +46.2% | 0.00% | – |
| Q2 2023 | $1,150,224 | -31.0% | 270,641 | -13.7% | 0.00% | – |
| Q1 2023 | $1,666,114 | -24.8% | 313,769 | -11.1% | 0.00% | -100.0% |
| Q4 2022 | $2,216,193 | +36861.2% | 352,897 | -37.9% | 0.00% | -50.0% |
| Q3 2022 | $5,996 | +687.9% | 568,329 | +305.0% | 0.00% | – |
| Q2 2022 | $761 | -100.0% | 140,318 | -49.8% | 0.00% | -100.0% |
| Q1 2022 | $2,566,000 | +436.8% | 279,458 | +780.9% | 0.00% | – |
| Q4 2021 | $478,000 | – | 31,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 544,196 | $5,741,000 | 19.52% |
| Elmwood Wealth Management, Inc. | 2,364,240 | $24,943,000 | 12.45% |
| 72 Investment Holdings, LLC | 474,067 | $5,001,000 | 3.96% |
| PFM Health Sciences, LP | 6,000,000 | $63,300,000 | 2.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 257,892 | $2,716,000 | 0.87% |
| Avidity Partners Management LP | 3,172,600 | $33,471,000 | 0.68% |
| Rokos Capital Management LLP | 1,907,509 | $20,811,000 | 0.62% |
| Green Alpha Advisors, LLC | 69,376 | $732,000 | 0.62% |
| Nelson Capital Management, LLC | 85,020 | $897,000 | 0.26% |
| Tekla Capital Management LLC | 567,147 | $5,983,000 | 0.24% |